|
[p]NASA exec quits weeks after getting to lead 2024 Moon landing plan[p]NASA executive Mark Sirangelo has quit around six weeks after being hired to lead the US' 2024 Moon landing's strategy. Sirangelo was named as Special Assistant to NASA Administrator Jim Bridenstine. His departure came after US lawmakers rejected NASA's proposal for a separate department within the agency to oversee future lunar missions and ultimately develop a human exploration of Mars.[p]₹14.7 crore gene therapy approved by US becomes most expensive drug[p]US' Food and Drug Administration has approved Swiss drugmaker Novartis' $2.1-million (₹14.7-crore), one-time gene therapy Zolgensma for treatment of a rare disease that afflicts infants, making it the world's most expensive drug. Defending the price, Novartis executives said that a one-time treatment is better than expensive long-term treatments that cost several hundred thousand dollars a year.[p]Fungi that draws gold particles from its surroundings found[p]Australia's national science agency CSIRO has discovered new thread-like fungi that oxidise tiny particles of gold from their surroundings and attach the gold to their strands. The fungi, Fusarium oxsporum, were found to grow larger and spread faster than those that don't interact with gold. "Gold is so chemically inactive that this interaction is both unusual and surprising," researchers said. |
|